Anna Moy
Optometrist · Hillsborough, NJNPI 1083835177
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $602 of the $673 with a category attached, or 89.5%. 11 manufacturers reported payments, led by Alcon at 33.7% of the total. Reporting peaked in 2023 at $170 and has fallen 65.3% since, to $59 in 2025. That places this record below the midpoint for optometrist clinicians in NJ, where the typical reported total is $671.
Across 33 payments — averaging $20.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$227
- Coopervision Inc.$108
- Visioneering Technologies, Inc.$66
- Rxsight Inc$64
- Bausch & Lomb Americas Inc.$56
- AbbVie$44
- plus $108 from 5 others
What the payments were for
- Speaking & faculty fees$507%
- Food & beverage$60289%
- Entertainment$213%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 13 | $227 |
| Coopervision Inc. | 5 | $108 |
| Visioneering Technologies, Inc. | 2 | $66 |
| Rxsight Inc | 1 | $64 |
| Bausch & Lomb Americas Inc. | 4 | $56 |
| AbbVie | 1 | $44 |
| Sun Pharmaceutical Industries Inc. | 3 | $43 |
| Optos, Inc. | 1 | $21 |
| Oyster Point Pharma, Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
| Tarsus Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$673 in reported general payments places this provider in the 50th percentile of 1,357 optometrist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Loteprednol Etabonate | 15 | $2,856 |
| Latanoprost | 13 | $109 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Hillsborough
- Kerry GelbWoodbridge$264K
- Rodolfo RodriguezNorth Bergen$244K
- Steven SorkinFairfield$146K
- Paul VaccarellaRockaway$99K
- Ada NohCinnaminson$74K
- Melanne RosettaIselin$66K
- Frank BuccieroSpringfield$57K
- Victoria DzurinkoDeptford$47K
- Michael McAleeseHowell$33K
- Gary RochaParamus$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.